Design of the revascularization with open bypass vs angioplasty and stenting of the lower extremity trial (ROBUST): A randomized clinical trial

JAMA Surgery

Volumn 149, Issue 12, 2014, Pages 1289-1295

  Malas, Mahmoud B ^a,b   Qazi, Umair ^a   Glebova, Natalia ^a   Arhuidese, Isibor ^a   Reifsnyder, Thomas ^a   Black, James ^a   Perler, Bruce A ^a   Freischlag, Julie A ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c JAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

AMPUTATION FREE SURVIVAL; ANKLE BRACHIAL INDEX; ARTICLE; COST EFFECTIVENESS ANALYSIS; CRITICAL LIMB ISCHEMIA; DIABETES CONTROL; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; FEMOROPOPLITEAL BYPASS; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL READMISSION; HOSPITALIZATION COST; HUMAN; HYPERTENSION; INTERMITTENT CLAUDICATION; LIMB SALVAGE; MAJOR CLINICAL STUDY; MORBIDITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; SMOKING CESSATION; STUDY DESIGN; SURGICAL MORTALITY; SURVIVAL; VASCULAR STENT; WEIGHT REDUCTION; WOUND HEALING; ADULT; AGED; ANGIOPLASTY; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; INCIDENCE; LEG; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROSTHESIS; STENT; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS; UNITED STATES; VASCULAR SURGERY; VASCULARIZATION;

ADULT; AGED; ANGIOPLASTY; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTERMITTENT CLAUDICATION; LOWER EXTREMITY; MALE; MARYLAND; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; QUALITY OF LIFE; STENTS; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 84919598589     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2014.369     Document Type: Article

References (27)

1. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71(3): 510-515.
2. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease: the San Luis Valley Diabetes Study. Circulation. 1995;91(5): 1472-1479.
3. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110(6): 738-743.
4. AbuRahma AF, Robinson PA, Holt SM. Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses. Surgery. 1999;126(4): 594-602.
5. JohnsonWC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg. 2000;32(2): 268-277.
6. Klinkert P, van Dijk PJ, Breslau PJ. Polytetrafluoroethylene femorotibial bypass grafting: 5-year patency and limb salvage. Ann Vasc Surg. 2003;17(5): 486-491.
7. Dormandy JA, Rutherford RB; TASCWorking Group. Management of peripheral arterial disease (PAD). J Vasc Surg. 2000;31(1, pt 2): S1-S296.
8. Norgren L, HiattWR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC IIWorking Group. Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(1)(suppl 1): S5-S67.
9. Laird JR, Katzen BT, Scheinert D, et al; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3(3): 267-276.
10. Krankenberg H, Schlüter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST). Circulation. 2007;116(3): 285-292.
11. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354(18): 1879-1888.
12. Hobson RW II, MackeyWC, Ascher E, et al; Society for Vascular Surgery. Management of atherosclerotic carotid artery disease: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg. 2008;48(2): 480-486.
13. Malas MB, Enwerem N, Qazi U, et al. Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease. J Vasc Surg. 2014;59(1): 129-135.
14. Adam DJ, Beard JD, Cleveland T, et al; BASIL trial participants. Bypass vs angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;(9501): 366: 1925-1934.
15. Morgan MB, Crayford T, Murrin B, Fraser SC. Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg. 2001;33(4): 679-687.
16. Sabeti S, MlekuschW, Amighi J, Minar E, Schillinger M. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther. 2005;12(1): 6-12.
17. de VriesM, Ouwendijk R, Kessels AG, et al. Comparison of generic and disease-specific questionnaires for the assessment of quality of life in patients with peripheral arterial disease. J Vasc Surg. 2005;41(2): 261-268.
18. Sabeti S, Schillinger M, Amighi J, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology. 2004;232(2): 516-521.
19. Bendermacher BL, Willigendael EM, Teijink JA, Prins MH. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev. 2006; (2): CD005263.
20. Wolf GL, Wilson SE, Cross AP, Deupree RH, Stason WB; Principal Investigators and Their Associates of Veterans Administration Cooperative Study Number 199. Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. J Vasc Interv Radiol. 1993;4(5): 639-648.
21. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 2001;12(1): 23-31.
22. Grimm J, Müller-Hülsbeck S, Jahnke T, Hilbert C, Brossmann J, HellerM. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol. 2001;12(8): 935-942.
23. Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, vd Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol. 1997;20(6): 420-425.
24. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106(12): 1505-1509.
25. Lugmayr HF, Holzer H, Kastner M, Riedelsberger H, Auterith A. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: amidterm follow-up. Radiology. 2002;222(1): 37-43.
26. Duda SH, BosiersM, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16(3): 331-338.
27. Duprez D, de Backer T, de Buyzere M, Clement DL. Estimation of walking distance in intermittent claudication: need for standardization. Eur Heart J. 1999;20(9): 641-644.